Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?

[1]  A. Bottomley,et al.  Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H. Brenner,et al.  Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  L. Collette,et al.  Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Norman,et al.  Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Piccart,et al.  Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. , 2004, European journal of cancer.

[6]  F. Fang,et al.  Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy , 2004, Cancer.

[7]  W. Scheithauer,et al.  Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Paul Glare,et al.  A systematic review of physicians' survival predictions in terminally ill cancer patients , 2003, BMJ : British Medical Journal.

[9]  R. Labianca,et al.  Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. , 2003, European journal of cancer.

[10]  D. Roychowdhury,et al.  Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  G. Molenberghs,et al.  Multicollinearity in prognostic factor analyses using the EORTC QLQ‐C30: identification and impact on model selection , 2002, Statistics in medicine.

[12]  A. Norman,et al.  Baseline quality of life predicts survival in patients with advanced colorectal cancer. , 2002, European journal of cancer.

[13]  W. Scheithauer,et al.  Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  J. Bergh,et al.  Timing of quality of life (QoL) assessments as a source of error in oncological trials. , 2001, Journal of advanced nursing.

[15]  Ali Montazeri,et al.  Quality of life in lung cancer patients: as an important prognostic factor. , 2001, Lung cancer.

[16]  M. Buyse,et al.  Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer , 2001, British Journal of Cancer.

[17]  R. Gelber,et al.  Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  N. Aaronson,et al.  The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  N Urban,et al.  Quality of life in survivors of colorectal carcinoma , 2000, Cancer.

[20]  F. Lévi,et al.  Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M Schumacher,et al.  Resampling and cross-validation techniques: a tool to reduce bias caused by model building? , 1997, Statistics in medicine.

[22]  C. Glover,et al.  Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  T R Fleming,et al.  Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  K R Hess,et al.  Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. , 1995, Statistics in medicine.

[25]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[26]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[27]  D. Cunningham,et al.  The chemotherapy of colon cancer can no longer be ignored. , 1993, European journal of cancer.

[28]  M Schumacher,et al.  A bootstrap resampling procedure for model building: application to the Cox regression model. , 1992, Statistics in medicine.

[29]  D. Cox.  Regression Models and Life-Tables , 1972 .

[30]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[31]  M. Friedman.  The Use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of Variance , 1937 .